Latest Posts

Access to services for people with multiple sclerosis (MS) is well known to be varied, with phrases like ‘postcode lottery’ and ‘patchy’ commonly used to describe people’s access to the care and support that they need. Anecdotally known of for some time, recent evidence now highlights not just the variation, but the impact it has […]

New disease-modifying drug Ocrelizumab could be the treatment that many people with primary-progressive MS have been waiting for, but despite positive clinical outcomes, it has yet to be licensed here in the UK. Multiple sclerosis (MS) causes inflammation of the nerve cells in the brain and spine, and disease-modifying therapies (DMTs) are a form of […]

Congratulations are thoroughly deserved by our latest MS MasterClass project winners. The most recent cohort of delegates to complete their intermodule projects met last night at their Awards dinner during this Autumn MasterClass course. MS specialist nurse Daisy Cam won the Project Award for her research into the use of alternative therapies in treating MS. […]

We live in a technological era and seldom a moment goes by when we are not using some sort of device or app, browsing the internet or relating across social media. Healthcare has long seemed behind in using these advances in technology to improve their services, but this is beginning to change. Exciting headway From […]

By Prof Gavin Giovannoni Article originally published on 5 July 2018 on the Barts MS Blog   Today is the NHS’ 70th Birthday. Happy Birthday we love you! We know you are the best value for money health service in the world and that you try your best with limited resources. We want to pledge […]

Experts in multiple sclerosis (MS) have recently recommended changes to the widely used diagnostic criteria for the condition. The McDonald criteria, first published in 2010, allows diagnosis of MS after one relapse, if an MRI imaging scan shows evidence of damage to the brain through lesions developing. Lately experts have gathered to review the criteria, […]

The Neurology Academy continues to expand as our work broadens, and we are pleased to welcome a new member of our team, Jamie McGregor. Jamie, whose background is predominantly in law, joins us as Head of Policy, Intelligence and External Affairs. He will be heading up our work in response to the new multiple sclerosis […]

Last night, the winners of the 2018 MS MasterClass intermodule delegate projects were announced. Dr Rachel Dorsey-Campbell was voted winner by her peer group and faculty for implementing a pharmacy-led prescribing and monitoring service for natalizumab. Her research found that the new service resulted in better monitoring of patient health when being treated, making the […]

Following the successful completion of a quality improvement pilot in orthopaedic surgery entitled Getting It Right First Time (GIRFT), the Department of Health and NHS Improvement (NHSI) have commissioned an expansion of the GIRFT programme that will cover an additional 35 clinical areas over four years from April 2017 to support providers in delivering clinical […]

We are delighted to announce that Dr Bindu Yoga, an MS MasterClass graduate, has recently had a poster selected by the Association of British Neurologists (ABN) for her work on timely access to disease-modifying treatments (DMTs) in multiple sclerosis (MS). Current guidelines say treatment should start ‘as soon as possible’ after a decision is made, […]